Ascher NL - Search Results

1

The potential supply of organ donors. An assessment of the efficacy of organ procurement efforts in the United States.

Evans RW, Orians CE, Ascher NL. Evans RW, et al. Among authors: ascher nl. JAMA. 1992 Jan 8;267(2):239-46. JAMA. 1992. PMID: 1727520

2

Designation of liver transplant centers in the United States.

Ascher NL, Evans RW. Ascher NL, et al. Transplant Proc. 1987 Feb;19(1 Pt 3):2405. Transplant Proc. 1987. PMID: 3274526 No abstract available.

3

Estimates of organ-specific donor availability for the United States.

Orians CE, Evans RW, Ascher NL. Orians CE, et al. Among authors: ascher nl. Transplant Proc. 1993 Feb;25(1 Pt 2):1541-2. Transplant Proc. 1993. PMID: 8442181 No abstract available.

4

Immunosuppressive therapy as a determinant of transplantation outcomes.

Evans RW, Manninen DL, Dong FB, Ascher NL, Frist WH, Hansen JA, Kirklin JK, Perkins JD, Pirsch JD, Sanfilippo FP. Evans RW, et al. Among authors: ascher nl. Transplantation. 1993 Jun;55(6):1297-305. doi: 10.1097/00007890-199306000-00017. Transplantation. 1993. PMID: 8516817 Clinical Trial.

5

Quantifying Sex-Based Disparities in Liver Allocation.

Locke JE, Shelton BA, Olthoff KM, Pomfret EA, Forde KA, Sawinski D, Gray M, Ascher NL. Locke JE, et al. Among authors: ascher nl. JAMA Surg. 2020 Jul 1;155(7):e201129. doi: 10.1001/jamasurg.2020.1129. Epub 2020 Jul 15. JAMA Surg. 2020. PMID: 32432699 Free PMC article.

6

Cell subsets responding to purified hepatocytes and evidence of indirect recognition of hepatocyte major histocompatibility complex class I antigen. I. The role of L3T4+ T cells in the development of allospecific cytotoxicity in hepatocyte-sponge matrix allografts.

Bumgardner GL, Chen S, Almond PS, Bach FH, Ascher NL, Matas AJ. Bumgardner GL, et al. Among authors: ascher nl. Transplantation. 1992 Apr;53(4):857-62. doi: 10.1097/00007890-199204000-00028. Transplantation. 1992. PMID: 1566351

7

Cell subsets responding to purified hepatocytes and evidence of indirect recognition of hepatocyte major histocompatibility complex class I antigen. II. In vitro-generated "memory" cells to class I+ class II- hepatocytes.

Bumgardner GL, Chen S, Almond PS, Bach FH, Ascher NL, Matas AJ. Bumgardner GL, et al. Among authors: ascher nl. Transplantation. 1992 Apr;53(4):863-8. doi: 10.1097/00007890-199204000-00029. Transplantation. 1992. PMID: 1566352

8

Efficacy and toxicity of FK 506 for the treatment of resistant rejection in liver transplant patients.

Hebert MF, Ascher NL, Lake JR, Roberts JP. Hebert MF, et al. Among authors: ascher nl. Transplant Proc. 1991 Dec;23(6):3109-10. Transplant Proc. 1991. PMID: 1721373 No abstract available.

9

Freise CE, Rowley H, Lake J, Hebert M, Ascher NL, Roberts JP. Freise CE, et al. Among authors: ascher nl. Transplant Proc. 1991 Dec;23(6):3173-4. Transplant Proc. 1991. PMID: 1721397 No abstract available.

10

Comparison of three regimens for cytomegalovirus prophylaxis in 147 liver transplant recipients.

Freise CE, Pons V, Lake J, Burke E, Ascher NL, Roberts JP. Freise CE, et al. Among authors: ascher nl. Transplant Proc. 1991 Feb;23(1 Pt 2):1498-500. Transplant Proc. 1991. PMID: 1846470 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

379 results

Search Page